News
Drug firms cut doctors’ fees for drug talks
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2021 (Published 07 March 2014) Cite this as: BMJ 2014;348:g2021- Michael McCarthy
- 1Seattle
In the face of new disclosure rules, a number of drug firms in the United States are dramatically reducing their payments to doctors for promotional speeches, an analysis by the non-profit, investigative news organization ProPublica has found.1
The analysis found that Eli Lilly’s payments to speakers dropped by 55%, from $47.9m (£28.6m; €34.5m) in 2011 to $21.6m in 2012. Over the same period …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.